Related Experiment Video

Updated: Jul 18, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Suppressive effect of modified dominant negative RAS mutant on human cancer by gene transfer with non-viral vector

Hayato Suzuki1, Satoshi Kuzumaki, Koji Nakagawa

  • 1Cancer Gene Regulation, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.

Cancer Biology & Therapy
|November 15, 2006
PubMed

Insights

Modified N116Y, a RAS mutant, effectively suppresses various cancer cell growth in vitro and in vivo. This modified gene shows promise for future human cancer gene therapy applications.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • The H-RAS mutant N116Y exhibits dominant negative activity and suppresses cancer cell growth.
  • Replication errors of N116Y raise concerns for clinical application due to potential carcinogenesis.
  • The carboxyl terminus of Ras is essential for its oncogenic function.

Purpose of the Study:

  • To develop a modified N116Y with reduced carcinogenic potential for cancer gene therapy.
  • To evaluate the growth-suppressing efficacy of a C-terminal deletion mutant of N116Y.

Main Methods:

  • Construction of a modified N116Y mutant (N116Y-Cdel2) by deleting the carboxyl terminus.
  • In vitro assessment of N116Y-Cdel2's effect on human cancer cell lines (HeLa, PCI43, SW480, LoVo, SAS).
  • In vivo evaluation of N116Y-Cdel2's suppressive effect on LoVo cells using the HVJ envelope nonviral gene transfer vector.

Main Results:

  • N116Y-Cdel2 demonstrated significant growth suppression across multiple human cancer cell lines in vitro.
  • The suppressive effect of N116Y-Cdel2 was confirmed in vivo in LoVo cells.
  • The modified N116Y mutant retained anti-cancer properties while addressing concerns of replication errors.

Conclusions:

  • The modified N116Y (N116Y-Cdel2) is a promising candidate for human cancer gene therapy.
  • Deletion of the carboxyl terminus mitigates oncogenic concerns associated with N116Y.
  • Further research into N116Y-Cdel2 could lead to novel therapeutic strategies for various cancers.

More Related Videos

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...